Zeidan AM - Search Results

1

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.

Bewersdorf JP, Shimony S, Shallis RM, Liu Y, Berton G, Schaefer EJ, Zeidan AM, Goldberg A, Stein E, Marcucci G, Bystrom RP, Lindsley RC, Chen EC, Ramos J, Stein A, Pullarkat V, Aldoss I, DeAngelo DJ, Neuberg DS, Stone RM, Garciaz S, Ball B, Stahl M. Bewersdorf JP, et al. Among authors: zeidan am. Am J Hematol. 2024 Aug;99(8):1640-1643. doi: 10.1002/ajh.27366. Epub 2024 May 15. Am J Hematol. 2024. PMID: 38751104 No abstract available.

2

Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.

Stahl M, Xu ML, Steensma DP, Rampal R, Much M, Zeidan AM. Stahl M, et al. Among authors: zeidan am. Ann Hematol. 2016 Jun;95(7):1197-200. doi: 10.1007/s00277-016-2664-4. Epub 2016 Apr 11. Ann Hematol. 2016. PMID: 27068405 Free PMC article. No abstract available.

3

Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.

Kim TK, Xu ML, Podoltsev NA, Prebet T, Barbarotta L, Amin K, Kasberg S, Roche K, Stahl M, Gore SD, Zeidan AM. Kim TK, et al. Among authors: zeidan am. Ann Hematol. 2016 Oct;95(11):1895-8. doi: 10.1007/s00277-016-2761-4. Epub 2016 Jul 29. Ann Hematol. 2016. PMID: 27468851 Free PMC article. No abstract available.

4

Emerging biological therapies for the treatment of myelodysplastic syndromes.

Zeidan AM, Stahl M, Komrokji R. Zeidan AM, et al. Expert Opin Emerg Drugs. 2016 Sep;21(3):283-300. doi: 10.1080/14728214.2016.1220534. Epub 2016 Aug 19. Expert Opin Emerg Drugs. 2016. PMID: 27486848 Review.

5

Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings.

Ball B, Zeidan A, Gore SD, Prebet T. Ball B, et al. Leuk Lymphoma. 2017 May;58(5):1022-1036. doi: 10.1080/10428194.2016.1228927. Epub 2016 Sep 21. Leuk Lymphoma. 2017. PMID: 27654579 Free PMC article. Review.

6

Epigenetics in Cancer: A Hematological Perspective.

Stahl M, Kohrman N, Gore SD, Kim TK, Zeidan AM, Prebet T. Stahl M, et al. Among authors: zeidan am. PLoS Genet. 2016 Oct 10;12(10):e1006193. doi: 10.1371/journal.pgen.1006193. eCollection 2016 Oct. PLoS Genet. 2016. PMID: 27723796 Free PMC article. Review.

7

Selecting initial treatment of acute myeloid leukaemia in older adults.

Podoltsev NA, Stahl M, Zeidan AM, Gore SD. Podoltsev NA, et al. Among authors: zeidan am. Blood Rev. 2017 Mar;31(2):43-62. doi: 10.1016/j.blre.2016.09.005. Epub 2016 Oct 8. Blood Rev. 2017. PMID: 27745715 Review.

8

Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities.

Stahl M, Kim TK, Zeidan AM. Stahl M, et al. Among authors: zeidan am. World J Stem Cells. 2016 Oct 26;8(10):316-331. doi: 10.4252/wjsc.v8.i10.316. World J Stem Cells. 2016. PMID: 27822339 Free PMC article. Review.

9

Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel?

Stahl M, Zeidan AM. Stahl M, et al. Among authors: zeidan am. Cancer. 2017 May 15;123(6):911-914. doi: 10.1002/cncr.30532. Epub 2017 Jan 17. Cancer. 2017. PMID: 28094843 Free article. No abstract available.

10

Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.

Stahl M, Zeidan AM. Stahl M, et al. Among authors: zeidan am. Cancer. 2017 May 15;123(10):1703-1713. doi: 10.1002/cncr.30585. Epub 2017 Feb 13. Cancer. 2017. PMID: 28192601 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters